Suzhou Basecare Medical Corporation Limited entered into an agreement to acquire a 51% stake in Suzhou Cellpro Biotechnology Co., Ltd. from Xue Zhigang, Huoke Investment and Hu Xiling for CNY 85 million on November 3, 2021. Xue Zhigang and Hu Xiling will be selling 20.84% and 24.71% respectivelyin Suzhou Cellpro Biotechnology Co., Ltd. The Consideration will be settled in cash and will be funded by the internal resources of the Group. Dr. Liang, will serve as chairman of the board of directors of Cellpro Biotech.